LSN 2463359
CAS: 1401031-52-4
Ref. 3D-BGC03152
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
- N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide
LSN 2463359 is a novel, potent, and selective allosteric modulator of the metabotropic glutamate receptor. It is currently in clinical development for the treatment of neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. LSN 2463359 has been shown to be safe and well tolerated in vivo studies in rats and mice. The drug improved ADHD-related symptoms in rodent models of ADHD. LSN 2463359 also reduced cataplexy episodes in narcoleptic patients who had been unresponsive to other treatments.
Propiedades químicas
Consulta técnica sobre: 3D-BGC03152 LSN 2463359
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
